Chargement en cours...
Safety of targeting ROR1 in primates with chimeric antigen receptor-modified T cells
Genetic engineering of T cells for adoptive transfer by introducing a tumor-targeting chimeric antigen receptor (CAR) is a new approach to cancer immunotherapy. A challenge for the field is to define cell surface molecules that are both preferentially expressed on tumor cells and can be safely targe...
Enregistré dans:
| Publié dans: | Cancer Immunol Res |
|---|---|
| Auteurs principaux: | , , , , , , , , |
| Format: | Artigo |
| Langue: | Inglês |
| Publié: |
2014
|
| Sujets: | |
| Accès en ligne: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4324006/ https://ncbi.nlm.nih.gov/pubmed/25355068 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1158/2326-6066.CIR-14-0163 |
| Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|